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achieved in all target vessels after further balloon angioplasty or
stenting.
Conclusions: TheFrontrunnerXPCTOcatheter is safe andeffective
for successful recanalization of CTO of femoropopliteal arteries
and it should be an alternative method after guidewire failure.
Effect of contrast media in patients with CKD
undergoing PCI
P. Ramya, D. Seshagiri Rao, B. Srinivas, Barik, Siva Prasad
NIMS, Hyderabad, India
Background: To assess the influence of contrast media over the
renal function in patients of CKD.
Methods: Retrospectively 50 patients have been studied. Data
regarding patient risk factors, LV function was collected. Renal
function (creatinine clearance) pre, post procedure was assessed
with Cockraft-Gault formula. All patients were given adequate pre
and post procedure hydration. High dose atorvastatin (80mg) on the
day of the procedure. Patients were monitored for 5 days following
the procedure with daily Biochemical analysis (Bl.Urea, S.crea-
tinine,Na+,K+,Cl- ).Also strict vigilance was maintained for develop-
ment of local complications like hematoma , pseudo aneurysm etc.
Results: Out of 50 patients, 31 were diabetics, all were hyperten-
sives, 14 persons were smokers.>50% of the patients had hyper-
tension. Most common procedure was PTCA. 10 patients were
already on renal replacement therapy. One of the patients studied
developed significant renal dysfunction following the procedure
requiring dialysis, later expired (underwent irregular dialysis
sessions & follow up). Another patient who used to get recurrent
episodes of accelerated hypertension, LVF, died of the same dur-
ing follow-up after PTCA. In the rest of the patients there was no
worsening of renal function.
Conclusion: Percutaneous interventions requiring contrast expo-
sure are safe even in patients with renal derangement, provided
adequate protective measures are taken.
Microalbuminuria as a risk factor for contrast-
induced nephropathy
P. Mittal, C.M. Varma, R. Thakur, R.P.S. Bhardwaz, M. Ahmad,
R.K. Bansal, U. Pandey, S.K. Sinha, P. Kumar
Department of cardiology, LPS institute of Cardiology, Kanpur, India
Background: CIN is one of the most important causes of acute
renal failure in hospitalized patients with the incremental use of
contrast media. We aimed to investigate whether micro-
albuminuria may act as a risk factor for CIN in patients with CAD
undergoing percutaneous intervention.
Methods: 70 hospitalized patients (37 men, 33 women) with CAD,
microalbuminuria and estimated glomerular filtration rate (eGFR)
of >60mL/min/1.73m2, whowere exposed to contrastmedia were
compared prospectively with matched cohart of 70 patients (36
men, 34 women) without microalbuminuria. Microalbuminuria
defined as 30-300 mg albumin/24 urine. All patients received
prophylaxis against CIN with 0.9% intravenous saline. CIN is
defined as either a 25% higher increase in serum creatinine (sCr)
from the baseline levels or a 0.5 mg/dL increase in sCr at 72 h after
contrast media exposure.
Results: The incidence of CIN was significantly higher than in
matched patients without microalbuminuria (17.1% vs 7.1%,
p<0.05). Correlation is more significant in patients with higher
volume (>150ml) of contrast use (32% vs 11.5% p-value <0.01).
Conclusion: Microalbuminuria may be a new risk factor for the
development of CIN in patients of CAD undergoing percutaneous
intervention especially in patients with expected high volume of
contrast use.
Experience of Left main (LM) percutaneous
transluminal coronary angioplasty (PTCA) at JJ
Hospital
D.K. Ware, N.O. Bansal, S. Prabhu, S. Shivapuje
GMC and JJ Hospital, Mumbai, India
Background: LM PTCA was an indication for CABG. But, LM PTCA
is becoming upcoming method for the same. We present experi-
ence of LM PTCA at our institute.
Methods: Patients presenting with ACS or CSA were subjected to
CAG. Those having LM significant (>50%) lesion were included in
study. Patients were explained the options for revascularization
and consent were taken from those opting PTCA. Patients were
loaded with 60 mg prasugrel or 600 mg clopidogrel. All patients
were stented with DES (Evorolimus/Zotarolimus). Pre and post
procedure intravascular ultrasound (IVUS) was used. Injectable
heparin was used intra and postoperatively. All patients were
given aspirin and prasugrel/clopidogrel.
Patients were followed up by regular outpatient visit. Those
having chest pain were subjected to CAG.
Results: Total 46 patients underwent LM PTCA. 26(56.52%) were
males and 20(43.47%) were females. Mean age was 55 years.
38(82.60%) had HTN, 5(10.86%) were DM. 18(39.13%) were smoking.
28(60.86%) had dyslipidemia.
2 (4.34%) had AMI. 3(6.42%) had NSTEMI. 6(13.06%) had unstable
angina. 35(76.08%) presented with CSA. Mean LVEF was 53.86%
24 (57.17%) patients had only LM lesion. Out of these, 5(10.86%)
had ostial LM lesion, 12(26.08%) had mid LM lesion, 7(15.21%) had
distal LM lesion. 9(19.56%) had LM plus ostial LAD lesion. 6(13.04%)
had LM plus non ostial LAD lesion. 3(6.42%) had LM plus LCX le-
sions. 3(6.42%) had LM plus RCA lesion. 1(2.17%) had LM plus
multivessel lesions.
3(6.52%) died during immediate postoperative period. Out of
them, 1 presented with AMI in poor general condition, second had
contrast induced nephropathy and third had multiple comorbid-
ities who refused CABG. 3(6.52%) lost follow up, 3(6.42%) died out
of hospital with unknown etiology. We performed CAG at mean 1
year follow up in 25(80.43%) patients, out of them 5(20%) had chest
pain and among them 2 had de novo lesions in other vessel. All
other patients had normal coronaries.
Conclusion: LM PTCA is an upcoming alternative for CABG and
has good success.
Experience of percutaneous transluminal
coronary angioplasty (PTCA) in post coronary
artery bypass (CABG) patients at JJ Hospital
D.K. Ware, N.O. Bansal, S. Prabhu, S. Shivapuje
GMC and JJ Hospital, Mumbai, India
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Background: Multivessel and LM lesions, CTO are the indications
of CABG. But currently, it is possible to do PTCA in patients with
coronary ischemia, even after CABG
Methods: 3 years data was analysed in post CABG patients. Details
of CABG, current disease and CAG were noted. PTCA was done
with DES or BMS. Patients were followed up on OPD basis
Results: There were 24 post CABG patients who underwent
attempted PTCA. Mean time of presentation after CABG was 8.6
years. Mean age was 56.63 years. 13 (54.16%) were male,
11(45.88%) were female. DM, HTN, dyslipidemia were present in
14(54.33%), 17(70.83%), 16(66.66%) respectively. Avg LVEF was
40.68%.
Presentation at the time of CABG was CSA, STEMI, NSTEMI, USA
in 3(12.5%), 8 (33.33%), 7(29.16%), 6(25%) respectively and presen-
tation at the time of PTCA was 12(50%), 2(8.33%), 4(16.66%), 6(25%)
respectively
During CABG, 24(100%) had LIMA to LAD graft. SVG graft was
used for RCA, LCX, RCA and LCX in 8(20.83%), 5(12.5%), 10(54.33%)
respectively. 1 (8.33%) had RIMA to RCA graft.
During CAG, total and subtotal occlusion was present in
6(33.33%) and 5(27.77%) patients in LAD, 5(27.77%) and 4(22.22%)
patients in RCA, 4(22.22%) and 2(11.11%) patients in LCX respec-
tively. 6 (25%) had lesion in SVG graft.
In 20 (83.33%) patients, total 26 lesions in native vessels were
attempted. 2(7.69%) could not be opened because of CTO. 24 were
stented, had 9(34.61%) in LAD, 9(34.61%) in RCA and 6(25%) in LCX.
Total 23(88.46%) DES and 3(11.54%) BMS were used.
4(16.66%) underwent attempted PTCA to SVG graft. 3(75%) un-
derwent successful PTCA, all with BMS. During procedure, one
had graft perforation which was sealed with covered stent
All patients are following regularly in OPD. Mean follow up is
15.6 months. 5(23.80%) lost follow up. 6(28.57%) developed chest
pain who underwent stress thallium scan and all were negative.
3(14.28%) presented with ACS (2 USA,1 NSTMI), only 1 had instent
thrombosis.
Conclusion: Post CABG PTCA can be attempted in native vessel
and graft and has high success rate as in our institute
Can rotablation atherectomy bypass the bypass
surgery in ‘drug eluting stent’ era?
A.N. Patnaik, G. Ramesh, Jagadeeh Babu, P.V.R.C. Raju,
K. Naveenkrushna
Star Hospitals, Hyderabad, India
Background: The patients with heavily calcified lesions, espe-
cially in LAD or LM are referred to the surgeons. When patients
were unwilling for CABG, Rotablation atherectomy (RA) used to
be popular for mechanical debulking in bare-metal stent era but
later it became less popular as it was technically demanding
and outcomes following PTCA were not promising. This study
was done to evaluate our institutional experience with RA and
followed by DES implantation in heavily calcified coronary
lesions.
Methods: From August, 2012 to July, 2014 we had 18 cases of
heavily calcified de novo lesions that underwent RA followed by
DES implantation. The database at base line and all follow-up
visits were analyzed.
Results: A total of 18 patients underwent RA for heavily calcified
coronary lesions followed by DES implantation during the study
period. Of them 60% were diabetics. Multivessel disease was seen
in 6 patients. The lesions that had RA were eLAD (13), LCx (3) and
RCA (2). Of them 30% were either balloon-non-crossable or non-
dilatable (1.25 mm balloon). Procedural success was 17/18 (94.4 %).
There were no procedure related MACE at 30 days. At mean
follow-up of 5.5 ± 1.35 months, 1 developed CRF and 1 needed
elective CABG.
Conclusion: RA followed by DES was safe with promising acute
and short term results in patients with heavily calcified coronary
lesions and bypass surgery could be avoided in almost all of them.
Single center experience with bioresorbable
vascular scaffolds in ‘on-label’ and ‘off- label’
indications in PTCA
A.N. Patnaik, G. Ramesh, Jagadeeh Babu, P.V.R.C. Raju,
K. Naveenkrushna
Star Hospitals, Hyderabad, India
Background: Since its introduction in 2012, Bioresorbable Vascular
Scaffolds (BVS) had shown promising results when used in spec-
ified coronary lesions. The experience in ‘Off-label’ indications is
limited.
Methods: We studied the technical feasibility, immediate and
short-term outcome of usage of BVS the ‘real-world’ cases
including off-label indications in our institute over the last 2 years.
We used 30 devices in 20 patients during this period. Standard
protocols were followed for the choice of hardware and dual an-
tiplatelet agents. The data is analyzed for lesion characteristics,
immediate results and 30-day follow-up.
Results: Of the 865 patients that had undergone PTCA during the
study period, BVS were implanted in 20 patients (4 females). The
mean age was 58 ±2.05 years. Of them 60%were diabetics and 65%
were smokers. The location of the lesions was LAD (16), RCA (10),
LCx/OM (3) or Ramus (1). The size of devices most frequently used
included 3x 28 mm (13) 2.5 x28 mm(6) and 3x 18 mm (5).In 2 cases
lesions were ostial and in 3 cases two stents with overlapping had
to be done due to long segment disease. Multi-lesional PTCA was
done in 5 cases. Of the 30 devices, four were used in 1 patient,
three in 1, two in 5 and one each in rest of them. Procedural
success was obtained in 19/20 (95%) procedures. One patient
developed acute thrombosis in BVS on day one and had responded
to balloon dilation and tirofiban infusion. There was no MACE at
30 day and 3 month follow-up. One patient at 5 month follow-up
developed angina and had angiographic restenosis. Re-PTCA with
DES was done. Patient was symptom-free at follow-up 3 months
later.
Conclusions: In this real-world experience in a single center, with
implantation of 30 BVS, the immediate results and short-term
outcomes were very promising. Off-label use had been equally
rewarding in our study.
Unprotected left main coronary artery stenting: A
single unit experience
Y.V.C. Reddy, S.I. Singha
Apollo Main Hospital, Chennai, India
Background: Severe Unprotected LMCA disease, either isolated or
associated with other stenoses, is usually treated by CABG
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